XML 86 R66.htm IDEA: XBRL DOCUMENT v3.25.0.1
Collaborative and Licensing Arrangements - Ociperlimab Option, Collaboration and License Agreement and China Broad Market Development Agreement (Details)
$ in Thousands
1 Months Ended
Dec. 31, 2021
product
Jan. 31, 2022
USD ($)
Jan. 31, 2021
USD ($)
Research and development collaborative arrangements      
Number of products | product 5    
Novartis | Collaborative Arrangement      
Research and development collaborative arrangements      
Upfront cash payment received | $   $ 300,000 $ 650,000